Renaissance Capital logo

BioHeart , Nasdaq: BHRT

A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.

Industry: Health Care

First Day Return: -4.8%

Industry: Health Care

A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.
more less
IPO Data
IPO File Date 02/13/2007
Offer Price $5.25
Price Range $6.00 - $8.00
Offer Shares (mm) 1.1
Deal Size ($mm) $6
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/18/2008
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $6
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Sunrise, FL, United States
Founded 1999
Employees at IPO 22
Website www.bioheartinc.com

BioHeart (BHRT) Performance